Busca un médico

Cris M. Ida, M.D.

  1. Pathologist
Solicite una Consulta

Publicaciones

  1. Webb LM, Neth BJ, Raghunathan A, Greipp PT, Ida CM, Carabenciov ID, Ruff MW. A Case of Long-Term Survival After Glioblastoma, IDH-Wild Type. Neurologist. 2024 Jul 1; 29 (4):254-258 Epub 2024 July 01
    View PubMed
  2. Donev K, Sundararajan V, Johnson D, Balan J, Chambers M, Paulson VA, Scherpelz KP, Abdullaev Z, Quezado M, Cimino PJ, Pratt D, Valerio E, Alves de Castro JV, Carraro DM, Torrezan GT, Wolff BM, Kulikowski LD, Costa FD, Aldape K, Ida CM. Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered? J Neuropathol Exp Neurol. 2024 Apr 19; 83 (5):357-364
    View PubMed
  3. Nazem A, Lavezo J, Abdullaev Z, Aldape K, Quezado M, Cimino PJ, Pratt DW, Jenkins RB, Ida CM. Diffuse hemispheric glioma with H3-3B G34R mutation: Expanding the spectrum of histone H3 genes in diffuse hemispheric glioma, H3 G34-mutant. J Neuropathol Exp Neurol 2023 Dec 22; 83 (1):58-60
    View PubMed
  4. Koleilat A, Kumar V, Al Hmada Y, Milosevic D, Zheng G, Lopes MB, Ida CM. Concurrent TERT promoter C228T and C250T mutations in diffuse gliomas: Rare occurrence of intratumoral heterogeneity. J Neuropathol Exp Neurol. 2023 Nov 20; 82 (12):1044-1047
    View PubMed
  5. Meredith DM, Cooley LD, Dubuc A, Morrissette J, Sussman RT, Nasrallah MP, Rathbun P, Yap KL, Wadhwani N, Bao L, Wolff DJ, Ida C, Sukhanova M, Horbinski C, Jennings LJ, Farooqi M, Gener M, Ginn K, Kam KL, Sasaki K, Kanagal-Shamanna R, Alexandrescu S, Brat D, Lu X. ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients. Mod Pathol. 2023 Nov; 36 (11):100294 Epub 2023 July 31
    View PubMed
  6. Soontrapa P, Dyck PJ, Dyck PJB, Klein CM, Engelstad J, Davies J, Shahar S, Harmsen WS, Mandrekar J, Spinner RJ, Ida CM, Klein CJ. Sural nerve biopsy utility by masked assessment of individual histologic preparations. J Peripher Nerv Syst. 2023 Jun; 28 (2):191-201 Epub 2023 Apr 20
    View PubMed
  7. Raghunathan A, Ida CM, Westbroek EM, Gupta S, Jenkins RB, Giannini C, Aldape KD. Mutations of FH and IDH may induce gliomagenesis by similar mechanisms. J Neuropathol Exp Neurol 2022 Dec 19; 82 (1):99-100
    View PubMed
  8. Berry JF, Vidrine DW, Wojcik AA, Trivedi D, Keen J, Quezado M, Abdullaev Z, Ketchum C, Pratt D, Aldape K, Jenkins R, Ida CM. Glioblastoma, IDH-Wildtype Harboring a KIAA1549::BRAF Fusion: Report of a Case With Comprehensive Molecular Profiling. J Neuropathol Exp Neurol 2022 Nov 16; 81 (12):1026-1028
    View PubMed
  9. Yanchus C, Drucker KL, Kollmeyer TM, Tsai R, Winick-Ng W, Liang M, Malik A, Pawling J, De Lorenzo SB, Ali A, Decker PA, Kosel ML, Panda A, Al-Zahrani KN, Jiang L, Browning JWL, Lowden C, Geuenich M, Hernandez JJ, Gosio JT, Ahmed M, Loganathan SK, Berman J, Trcka D, Michealraj KA, Fortin J, Carson B, Hollingsworth EW, Jacinto S, Mazrooei P, Zhou L, Elia A, Lupien M, He HH, Murphy DJ, Wang L, Abyzov A, Dennis JW, Maass PG, Campbell K, Wilson MD, Lachance DH, Wrensch M, Wiencke J, Mak T, Pennacchio LA, Dickel DE, Visel A, Wrana J, Taylor MD, Zadeh G, Dirks P, Eckel-Passow JE, Attisano L, Pombo A, Ida CM, Kvon EZ, Jenkins RB, Schramek D. A noncoding single-nucleotide polymorphism at 8q24 drives IDH1-mutant glioma formation. Science. 2022 Oct 7; 378 (6615):68-78 Epub 2022 Oct 06
    View PubMed
  10. Milman T, Eiger-Moscovich M, Henry RK, Ida CM, Ruben M, Shields CL, Lally SE, Penne RB, Stefanyszyn MA, Bilyk JR, Rapuano CJ, Rabinowitz M, Eagle RC Jr. Cyclin D1 Expression and Molecular Genetic Findings in Periocular Histiocytoses and Neoplasms of Macrophage-Dendritic Cell Lineage. Am J Ophthalmol. 2022 Oct; 242:36-51 Epub 2022 May 18
    View PubMed
  11. Horak P, Griffith M, Danos AM, Pitel BA, Madhavan S, Liu X, Chow C, Williams H, Carmody L, Barrow-Laing L, Rieke D, Kreutzfeldt S, Stenzinger A, Tamborero D, Benary M, Rajagopal PS, Ida CM, Lesmana H, Satgunaseelan L, Merker JD, Tolstorukov MY, Campregher PV, Warner JL, Rao S, Natesan M, Shen H, Venstrom J, Roy S, Tao K, Kanagal-Shamanna R, Xu X, Ritter DI, Pagel K, Krysiak K, Dubuc A, Akkari YM, Li XS, Lee J, King I, Raca G, Wagner AH, Li MM, Plon SE, Kulkarni S, Griffith OL, Chakravarty D, Sonkin D. Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). Genet Med. 2022 Sep; 24 (9):1991
    View PubMed
  12. Horak P, Griffith M, Danos AM, Pitel BA, Madhavan S, Liu X, Chow C, Williams H, Carmody L, Barrow-Laing L, Rieke D, Kreutzfeldt S, Stenzinger A, Tamborero D, Benary M, Rajagopal PS, Ida CM, Lesmana H, Satgunaseelan L, Merker JD, Tolstorukov MY, Campregher PV, Warner JL, Rao S, Natesan M, Shen H, Venstrom J, Roy S, Tao K, Kanagal-Shamanna R, Xu X, Ritter DI, Pagel K, Krysiak K, Dubuc A, Akkari YM, Li XS, Lee J, King I, Raca G, Wagner AH, Li MM, Plon SE, Kulkarni S, Griffith OL, Chakravarty D, Sonkin D. Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). Genet Med. 2022 May; 24 (5):986-998 Epub 2022 Jan 29
    View PubMed
  13. Vasudevan A, Tooley AA, Ida CM. Orbital Inflammation in an Adult With Crohn Disease. JAMA Ophthalmol. 2022 Apr 1; 140 (4):426-427
    View PubMed
  14. Ida CM, Pulido J, Greipp PT, Garcia JJ, Olsen TW, Dalvin L, Salomao DR. BAP1 Immunostain Status in Intraocular Biopsy Specimens for Uveal Melanoma Highly Correlates with Other Prognostic Markers. Ocul Oncol Pathol. 2022 Feb; 8 (1):22-29 Epub 2021 Nov 15
    View PubMed
  15. Xu TT, Pulido JS, Parney IF, Ida CM, Dalvin LA, Olsen TW. Carbon Fiducial Markers for Tumor Localization in Stereotactic Irradiation of Uveal Melanoma. Ocul Oncol Pathol. 2021 Oct; 7 (5):368-375 Epub 2021 Aug 03
    View PubMed
  16. Ida CM, Johnson DR, Nair AA, Davila J, Kollmeyer TM, Minn K, Fadra NM, Balcom JR, Fung KA, Kim DK, Kaufmann TJ, Kipp BR, Halling KC, Jenkins RB, Giannini C. Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway Activation. J Neuropathol Exp Neurol. 2021 Sep 27; 80 (9):821-829
    View PubMed
  17. Pryzbylski AL, Kollmeyer TM, Praska CE, Raghunathan A, Jentoft ME, Giannini C, Vaubel RA, Halling KC, Zheng G, DiGuardo MA, Kipp BR, Jenkins RB, Ida CM. Non-canonical IDH Mutation Frequency in IDH1-R132H-Negative Glioblastoma Patients Older Than 54 Years. J Neuropathol Exp Neurol 2021 Sep 10; 80 (8):804-806
    View PubMed
  18. Eschbacher KL, Ida CM, Johnson DR, Alvi MA, Jenkins SM, Ruff MW, Kerezoudis P, Neth BJ, Pasion RM, Daniels DJ, Kizilbash SH, Raghunathan A. Diffuse Gliomas of the Brainstem and Cerebellum in Adults Show Molecular Heterogeneity. Am J Surg Pathol. 2021 Aug 1; 45 (8):1082-1090
    View PubMed
  19. Stephen Nix J, Ida CM. What Every Neuropathologist Needs to Know: Practical Aspects and Pitfalls in Molecular Diagnosis of Brain Tumors. J Neuropathol Exp Neurol. 2021 Apr 16; 80 (5):415-418
    View PubMed
  20. Zhao Y, Yu H, Ida CM, Halling KC, Kipp BR, Geiersbach K, Rumilla KM, Gupta S, Lin MT, Zheng G. Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases. JAMA Netw Open. 2021 Jan 04; 4(1):e2035479.
    View PubMed
  21. Milman T, Ida CM, Zhang PJL, Eagle RC Jr. Gene Fusions in Ocular Adnexal Tumors. Am J Ophthalmol. 2021 Jan; 221:211-225 Epub 2020 Aug 13
    View PubMed
  22. Salomao DR, Ida CM, Greipp PT, Carney JA. Case Report with Review of the Literature: Uveal Melanoma in a Patient with Carney Complex - Another Rare Component of the Syndrome? Ocul Oncol Pathol. 2020 Oct; 6 (5):311-317 Epub 2020 Apr 21
    View PubMed
  23. Milman T, Zhang Q, Ang S, Elder D, Ida CM, Salomao DR, Lally SE, Shields JA, Hamershock RA, Sioufi K, Shields CL, Eagle RC Jr. Conjunctival nevi and melanoma: multiparametric immunohistochemical analysis, including p16, SOX10, HMB45, and Ki-67. Hum Pathol. 2020 Sep; 103:107-119 Epub 2020 July 21
    View PubMed
  24. Zepeda-Mendoza CJ, Vaubel RA, Zarei S, Ida CM, Matthews M, Acree S, Raghunathan A, Giannini C, Jenkins RB. Concomitant 1p/19q co-deletion and IDH1/2, ATRX, and TP53 mutations within a single clone of "dual-genotype" IDH-mutant infiltrating gliomas. Acta Neuropathol. 2020 Jun; 139 (6):1105-1107 Epub 2020 Mar 13
    View PubMed
  25. Ball MK, Kollmeyer TM, Praska CE, McKenna ML, Giannini C, Raghunathan A, Jentoft ME, Lachance DH, Kipp BR, Jenkins RB, Ida CM. Frequency of false-positive FISH 1p/19q codeletion in adult diffuse astrocytic gliomas. Neurooncol Adv. 2020 Jan-Dec; 2 (1):vdaa109 Epub 2020 Aug 27
    View PubMed
  26. Burgenske DM, Yang J, Decker PA, Kollmeyer TM, Kosel ML, Mladek AC, Caron AA, Vaubel RA, Gupta SK, Kitange GJ, Sicotte H, Youland RS, Remonde D, Voss JS, Fritcher EGB, Kolsky KL, Ida CM, Meyer FB, Lachance DH, Parney IJ, Kipp BR, Giannini C, Sulman EP, Jenkins RB, Eckel-Passow JE, Sarkaria JN. Molecular profiling of long-term IDH-wildtype glioblastoma survivors. Neuro Oncol. 2019 Nov 4; 21 (11):1458-1469
    View PubMed
  27. Blessing MM, Blackburn PR, Krishnan C, Harrod VL, Barr Fritcher EG, Zysk CD, Jackson RA, Milosevic D, Nair AA, Davila JI, Balcom JR, Jenkins RB, Halling KC, Kipp BR, Nageswara Rao AA, Laack NN, Daniels DJ, Macon WR, Ida CM. Desmoplastic Infantile Ganglioglioma: A MAPK Pathway-Driven and Microglia/Macrophage-Rich Neuroepithelial Tumor. J Neuropathol Exp Neurol. 2019 Nov 1; 78 (11):1011-1021
    View PubMed
  28. Milman T, Salomao DR, Ida CM, Capiz Correa DR, Grossniklaus HE, Zhang Q, Hamershock RA, Shields C, Shields JA, Raber I, Rapuano CJ, Patel R, Eagle RC Jr. Conjunctival Myxoid Lesions: Clinical-Pathologic Multiparametric Analysis, Including Molecular Genetics (An American Ophthalmological Society Thesis). Am J Ophthalmol. 2019 Sep; 205:115-131 Epub 2019 May 10
    View PubMed
  29. Alvi MA, Ida CM, Paolini MA, Kerezoudis P, Meyer J, Barr Fritcher EG, Goncalves S, Meyer FB, Bydon M, Raghunathan A. Spinal cord high-grade infiltrating gliomas in adults: clinico-pathological and molecular evaluation. Mod Pathol. 2019 Sep; 32 (9):1236-1243 Epub 2019 Apr 26
    View PubMed
  30. Ida CM, Lundquist PA, Weck K, Highsmith WE Jr. The Power of Proficiency Testing: Unraveling Single-Nucleotide Polymorphism Interference, With Potential Impact on Clinical Testing of Spinocerebellar Ataxia Type 3. Arch Pathol Lab Med. 2019 Mar; 143 (3):349-355 Epub 2018 Nov 01
    View PubMed
  31. Wieben ED, Aleff RA, Basu S, Sarangi V, Bowman B, McLaughlin IJ, Mills JR, Butz ML, Highsmith EW, Ida CM, Ekholm JM, Baratz KH, Fautsch MP. Amplification-free long-read sequencing of TCF4 expanded trinucleotide repeats in Fuchs Endothelial Corneal Dystrophy. PLoS One. 2019; 14 (7):e0219446 Epub 2019 July 05
    View PubMed
  32. Ida CM, Butz ML, Lundquist PA, Dawson DB. C9orf72 Repeat Expansion Frequency among Patients with Huntington Disease Genetic Testing. Neurodegener Dis. 2018; 18 (5-6):239-253 Epub 2018 Oct 18
    View PubMed
  33. Ida CM, Butz ML, Jenkins RB, Sarkaria JN, Kitange GJ, Giannini C, Kipp BR. Real-Time Methylation-Specific Polymerase Chain Reaction for MGMT Promoter Methylation Clinical Testing in Glioblastoma: An Alternative Detection Method for a Heterogeneous Process. Am J Clin Pathol. 2017 Oct 1; 148 (4):296-307
    View PubMed
  34. Barrick BJ, Ida CM, Laniosz V, Jentoft ME, Sominidi-Damodaran S, Wieland CN, Meves A, Lehman JS. Bullous Pemphigoid, Neurodegenerative Disease, and Hippocampal BP180 Expression: A Retrospective Postmortem Neuropathologic Study. J Invest Dermatol 2016 Oct; 136 (10):2090-2092 Epub 2016 June 24
    View PubMed
  35. Ida CM, Dyck PJ, Engelstad JK, Wang W, Selcen D, Bodensteiner JB, Mauermann ML, Klein CJ. Pediatric Nerve Biopsy Diagnostic and Treatment Utility in Tertiary Care Referral. Pediatr Neurol. 2016 May; 58:3-11 Epub 2016 Feb 05
    View PubMed
  36. Ida CM, Rodriguez FJ, Burger PC, Caron AA, Jenkins SM, Spears GM, Aranguren DL, Lachance DH, Giannini C. Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up. Brain Pathol. 2015 Sep; 25 (5):575-86 Epub 2014 Dec 05
    View PubMed
  37. Kosari F, Ida CM, Aubry MC, Yang L, Kovtun IV, Klein JL, Li Y, Erdogan S, Tomaszek SC, Murphy SJ, Bolette LC, Kolbert CP, Yang P, Wigle DA, Vasmatzis G. ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation. Oncogene. 2014 Jul 17; 33 (29):3776-83 Epub 2013 Sept 16
    View PubMed
  38. Ida CM, Yan X, Jentoft ME, Kip NS, Scheithauer BW, Morris JM, Dogan A, Parisi JE, Kovacs K. Pituicytoma with gelsolin amyloid deposition. Endocr Pathol. 2013 Sep; 24 (3):149-55
    View PubMed
  39. Ida CM, Vrana JA, Rodriguez FJ, Jentoft ME, Caron AA, Jenkins SM, Giannini C. Immunohistochemistry is highly sensitive and specific for detection of BRAF V600E mutation in pleomorphic xanthoastrocytoma. Acta Neuropathol Commun. 2013 May 30; 1:20
    View PubMed
  40. Gomez CR, Kosari F, Munz JM, Schreiber CA, Knutson GJ, Ida CM, El Khattouti A, Karnes RJ, Cheville JC, Vasmatzis G, Vuk-Pavlovic S. Prognostic value of discs large homolog 7 transcript levels in prostate cancer. PLoS One. 2013; 8 (12):e82833 Epub 2013 Dec 09
    View PubMed
  41. Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27; 489 (7417):519-25 Epub 2012 Sept 09
    View PubMed
  42. Kosari F, Cheville JC, Ida CM, Karnes RJ, Leontovich AA, Sebo TJ, Erdogan S, Rodriguez E, Murphy SJ, Vasmatzis G. Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer. Am J Pathol. 2012 Jul; 181 (1):34-42 Epub 2012 May 26
    View PubMed
  43. Ida CM, Lambert SR, Rodriguez FJ, Voss JS, Mc Cann, Mc Cann BE, Seys AR, Halling KC, Collins VP, Giannini C. BRAF alterations are frequent in cerebellar low-grade astrocytomas with diffuse growth pattern. J Neuropathol Exp Neurol. 2012 Jul; 71 (7):631-9
    View PubMed
  44. Glazebrook KN, Kakar S, Ida CM, Laurini JA, Moder KG, Leng S. False-negative dual-energy computed tomography in a patient with acute gout. J Clin Rheumatol. 2012 Apr; 18: (3)138-41.
    View PubMed
  45. Ida CM, Scheithauer BW, Yapicier O, Carney JA, Wenger DE, Inwards CY, Bertoni F, Spinner RJ, Unni KK. Primary schwannoma of the bone: a clinicopathologic and radiologic study of 17 cases. Am J Surg Pathol. 2011 Jul; 35 (7):989-97
    View PubMed
  46. Shon W, Ida CM, Boland-Froemming JM, Rose PS, Folpe A. Cutaneous angiosarcoma arising in massive localized lymphedema of the morbidly obese: a report of five cases and review of the literature. J Cutan Pathol. 2011 Jul; 38 (7):560-4 Epub 2011 Apr 26
    View PubMed
  47. Karnes RJ, Cheville JC, Ida CM, Sebo TJ, Nair AA, Tang H, Munz JM, Kosari F, Vasmatzis G. The ability of biomarkers to predict systemic progression in men with high-risk prostate cancer treated surgically is dependent on ERG status. Cancer Res. 2010 Nov 15; 70 (22):8994-9002 Epub 2010 Nov 09
    View PubMed
  48. Bispo Junior RZ, Camargo OP, Ida CM, Baptista AM, Ribeiro MB, Bruno JM. Primary malignancy in giant cell tumor: a case report. Sao Paulo Med J. 2009 Sep; 127: (5)310-3.
    View PubMed
  49. Ida CM, Wang X, Erickson-Johnson MR, Wenger DE, Blute ML, Nascimento AG, Oliveira AM. Primary retroperitoneal lipoma: a soft tissue pathology heresy?: report of a case with classic histologic, cytogenetics, and molecular genetic features. Am J Surg Pathol. 2008 Jun; 32(6):951-4.
    View PubMed
  50. Ida CM, Rolig KA, Hulshizer RL, Van Dyke DL, Randolph JL, Jenkins RB, Nascimento AG, Oliveira AM. Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as a sole cytogenetic abnormality. Cancer Genet Cytogenet. 2007 Sep; 177(2):139-42.
    View PubMed
  51. Ida CM, Rodriguez FJ, Scheithauer BW, Kois N, Vanefsky M, Andersen BJ, Erickson B. Infiltrative chordoid meningioma of the pineal region: a study of 2 cases. Clin Neuropathol. 2007 May-Jun; 26(3):111-8.
    View PubMed
PST-20514277